Memphasys Ltd

ASX:MEM (Australia)  
A$ 0.01 (+12.5%) Jul 25
At Loss
P/B:
1.51
Market Cap:
A$ 11.06M ($ 7.25M)
Enterprise V:
A$ 16.58M ($ 10.87M)
Volume:
5.36M
Avg Vol (2M):
1.32M
Trade In:
Volume:
5.36M
At Loss
Avg Vol (2M):
1.32M

Business Description

Description
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset 0.5
Debt-to-Equity 0.84
Debt-to-EBITDA -1.64
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.57
Distress
Grey
Safe
Beneish M-Score -4.13
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate -26
3-Year Book Growth Rate -16.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 81.06
9-Day RSI 71.52
14-Day RSI 64.31
6-1 Month Momentum % -30
12-1 Month Momentum % -47.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.17
Quick Ratio 0.14
Days Inventory 1506.79
Days Sales Outstanding 6981.6
Days Payable 4548.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.7
Shareholder Yield % -17.91

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 44.68
Operating Margin % -10370.21
Net Margin % -9621.28
FCF Margin % -7674.47
ROE % -57.63
ROA % -31.23
ROIC % -28.87
ROC (Joel Greenblatt) % -173.89
ROCE % -44.53

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 1.51
EV-to-EBIT -3.89
EV-to-EBITDA -4.9
EV-to-Revenue 352.83
EV-to-FCF -4.21
Earnings Yield (Greenblatt) % -25.67
FCF Yield % -32.61

Financials

ASX:MEM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Memphasys Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.047
EPS (TTM) (A$) -0.004
Beta 0.87
Volatility % 42.46
14-Day RSI 64.31
14-Day ATR (A$) 0.000517
20-Day SMA (A$) 0.00755
12-1 Month Momentum % -47.81
52-Week Range (A$) 0.006 - 0.016286
Shares Outstanding (Mil) 1,382.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Memphasys Ltd Filings

Filing Date Document Date Form
No Filing Data

Memphasys Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Memphasys Ltd Frequently Asked Questions

What is Memphasys Ltd(ASX:MEM)'s stock price today?
The current price of ASX:MEM is A$0.01. The 52 week high of ASX:MEM is A$0.02 and 52 week low is A$0.01.
When is next earnings date of Memphasys Ltd(ASX:MEM)?
The next earnings date of Memphasys Ltd(ASX:MEM) is .
Does Memphasys Ltd(ASX:MEM) pay dividends? If so, how much?
Memphasys Ltd(ASX:MEM) does not pay dividend.

Press Release

Subject Date
No Press Release